GlassScriptPhysician profile
Krystle N Baker
NPI 1063739902
$1,568.00
in general payments reported to CMS, 2019-2025
18 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $88.05 · 2021: $75.97 · 2022: $102 · 2023: $870 · 2024: $141 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $648 · Travel and Lodging: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $647.85 |
| Travel and Lodging | $537.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $698.07 | 2023 | Altis |
| Pfizer INC. | $162.25 | 2019-2024 | |
| Abbvie INC. | $158.86 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $118.37 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $86.75 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $50.47 | 2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $46.61 | 2023-2025 | Slynd |
| Evofem Biosciences, INC. | $41.50 | 2023 | Phexxi |
| Pacira Pharmaceuticals Incorporated | $32.91 | 2024 | Exparel |
| Merck Sharp & Dohme LLC | $31.21 | 2019-2020 | |
| Organon LLC | $25.52 | 2024 | |
| Millicent US INC | $20.20 | 2025 | Femlyv |
| Sage Therapeutics, LLC | $19.14 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $17.12 | 2020 | |
| Roche Diagnostics Corporation | $17.06 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $15.88 | 2025 | The Cologuard Plus Collection Kit |
| Biofire Diagnostics, LLC | $13.04 | 2021 | |
| Biomerieux INC | $13.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krystle Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.